Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

C O N M E D Corp (CNMD)

C O N M E D Corp (CNMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,120,049
  • Shares Outstanding, K 30,891
  • Annual Sales, $ 1,245 M
  • Annual Income, $ 64,460 K
  • EBIT $ 198 M
  • EBITDA $ 276 M
  • 60-Month Beta 1.46
  • Price/Sales 1.74
  • Price/Cash Flow 11.45
  • Price/Book 2.30

Options Overview Details

View History
  • Implied Volatility 48.57% ( +4.22%)
  • Historical Volatility 36.24%
  • IV Percentile 85%
  • IV Rank 58.20%
  • IV High 63.81% on 10/30/24
  • IV Low 27.34% on 05/10/24
  • Put/Call Vol Ratio 0.38
  • Today's Volume 11
  • Volume Avg (30-Day) 4
  • Put/Call OI Ratio 0.15
  • Today's Open Interest 1,500
  • Open Int (30-Day) 1,488

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 1.21
  • Number of Estimates 4
  • High Estimate 1.21
  • Low Estimate 1.21
  • Prior Year 1.06
  • Growth Rate Est. (year over year) +14.15%

Price Performance

See More
Period Period Low Period High Performance
1-Month
68.15 +0.70%
on 12/20/24
78.00 -12.01%
on 11/25/24
-2.06 (-2.91%)
since 11/20/24
3-Month
61.45 +11.69%
on 10/10/24
78.00 -12.01%
on 11/25/24
-6.61 (-8.79%)
since 09/20/24
52-Week
61.05 +12.42%
on 04/25/24
114.80 -40.22%
on 12/27/23
-39.78 (-36.69%)
since 12/20/23

Most Recent Stories

More News
Conmed: Q3 Earnings Snapshot

Conmed: Q3 Earnings Snapshot

CNMD : 68.63 (-1.68%)
New Strong Sell Stocks for September 26th

Here are three stocks added to the Zacks Rank #24 (Strong Sell) List today:Amerant Bancorp Inc. AMTB is a bank holding company for Amerant Bank. The Zacks Consensus Estimate for its current year earnings...

BZH : 27.92 (+0.43%)
AMTB : 22.32 (-0.40%)
CNMD : 68.63 (-1.68%)
New Strong Sell Stocks for September 17th

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:Bayerische Motoren Werke BAMXF is a multi-brand automobile manufacturer that focuses on the premium segments of the worldwide automobile...

CNMD : 68.63 (-1.68%)
BZH : 27.92 (+0.43%)
BAMXF : 80.9086 (-1.33%)
Conmed: Q2 Earnings Snapshot

Conmed: Q2 Earnings Snapshot

CNMD : 68.63 (-1.68%)
Is the Worst Over for This Cheap Growth Stock?

After CONMED's 33% slump this year, does its sharp rally off the April lows suggest the worst is over for this growth stock?

CNMD : 68.63 (-1.68%)
$SPX : 5,930.85 (+1.09%)
XLV : 138.00 (+1.26%)
MCK : 579.74 (+0.09%)
ISRG : 524.43 (+0.10%)
Conmed: Q1 Earnings Snapshot

Conmed: Q1 Earnings Snapshot

CNMD : 68.63 (-1.68%)
Conmed: Q4 Earnings Snapshot

Conmed: Q4 Earnings Snapshot

CNMD : 68.63 (-1.68%)
Conmed: Q3 Earnings Snapshot

Conmed: Q3 Earnings Snapshot

CNMD : 68.63 (-1.68%)
Conmed: Q2 Earnings Snapshot

Conmed: Q2 Earnings Snapshot

CNMD : 68.63 (-1.68%)
Conmed: Q1 Earnings Snapshot

Conmed: Q1 Earnings Snapshot

CNMD : 68.63 (-1.68%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered...

See More

Key Turning Points

3rd Resistance Point 74.04
2nd Resistance Point 72.76
1st Resistance Point 70.70
Last Price 68.63
1st Support Level 67.36
2nd Support Level 66.08
3rd Support Level 64.02

See More

52-Week High 114.80
Fibonacci 61.8% 94.27
Fibonacci 50% 87.93
Fibonacci 38.2% 81.58
Last Price 68.63
52-Week Low 61.05

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar